Since November 2021, I am working as a senior physician at the University Hospital Tübingen (UKT), Department of Neurology & Stroke. I am responsible for the stroke unit, IMC, ICU and the emergency department. I did my residency starting in February 2011 in the university hospital of Munich (LMU) and completed my training in February 2019. During my training, I was primarily employed in neurological acute and intensive care. From December 2019 until October 2020, I was working in telemedicine for the Neurovascular Network of Southwest Bavaria (NEVAS). Scientifically, I first worked in the research group of Prof. Dr. M. Strupp on dizziness and balance disorders, especially vestibular and cerebellar disorders and their treatment options. I completed my habilitation in neurology on the topic "Improvement of the diagnosis of vertigo syndromes and therapy of cerebellar vertigo disorders" in March 2020. In the context of this scientific occupation, I raised a BMBF grant of 1,044,865 EUR for the now completed, multicenter, international ALCAT study (grant number: 01KG1422). However, as my clinical focus was - as mentioned above - mainly in acute/emergency and intensive care medicine, I decided to establish an additional scientific focus in vascular medicine (working group of Prof. Dr. L. Kellert). In the meantime, I have also published very successfully in this field, regarding the acute treatment options in stroke including intravenous thrombolysis, mechanical thrombectomy and clinical factors for success and outcome. Further funding I have obtained was in the context of a - currently ongoing - monocentric study on the efficacy of ipad-based speech therapy after stroke ("Lexi Study", funding amount 10.000 € by Boehringer Ingelheim).